Bunka Shutter (5930) Q2 2026 earnings summary

Executive summary

• Net sales for the first half rose 2.9% year-on-year to ¥105,276 million, with profit attributable to owners of parent up 24.3% to ¥2,746 million, despite a slight decline in operating profit by 0.7%.

• Ordinary profit increased 9.1% year-on-year, mainly due to foreign exchange gains, and interim net profit exceeded the previous year's results.

• The company maintained its full-year forecast, targeting net sales of ¥240 billion (up 5.1% year-on-year) and an operating profit margin of 7.0%, with favorable domestic orders since September.

• A new shareholder benefit program was introduced, and approximately ¥2.0 billion of treasury stock was acquired.

• A business strategy was formulated targeting sales over ¥300 billion, a share price above ¥3,000, and an operating profit margin above 10% by FY2030.

Financial highlights

• First half net sales rose to ¥105,276 million, up ¥2,978 million year-over-year, mainly due to higher sales volume and new revenue recognition standards.

• Operating profit for the first half was ¥3,863 million, down ¥27 million year-over-year, primarily due to increased costs.

• Ordinary profit and net profit attributable to owners of parent increased, supported by equity method investment profit, FX gains, and gains on sales of investment securities.

• Dividend per share for the first half was ¥37, up ¥5 year-over-year.

• Basic earnings per share increased to ¥38.78 from ¥31.05 year-on-year.

Outlook and guidance

• Full-year net sales are forecast at ¥240 billion, up 5.1% year-over-year, with operating profit expected to rise 14.1% to ¥16.8 billion.

• Profit attributable to owners of parent is forecast at ¥11,500 million, down 12.6% year-on-year.

• Annual dividend per share is projected at ¥74.

• Capital investment for the year is planned at ¥7.7 billion, focusing on production equipment and system upgrades.

• Capital and strategic investments planned at ¥35–45 billion over 2024–2026, with a focus on productivity, M&A, and R&D.